Dyne Therapeuticsinc Stock Market Capitalization
| DYN Stock | USD 25.44 0.41 1.59% |
Dyne TherapeuticsInc fundamentals help investors to digest information that contributes to Dyne TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Dyne Stock. The fundamental analysis module provides a way to measure Dyne TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dyne TherapeuticsInc stock.
Dyne |
Dyne TherapeuticsInc Company Market Capitalization Analysis
Dyne TherapeuticsInc's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current Dyne TherapeuticsInc Market Capitalization | 2.23 B |
Most of Dyne TherapeuticsInc's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dyne TherapeuticsInc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
| Competition |
Based on the recorded statements, the market capitalization of Dyne TherapeuticsInc is about 2.23 B. This is 82.79% lower than that of the Biotechnology sector and 53.01% lower than that of the Health Care industry. The market capitalization for all United States stocks is 88.29% higher than that of the company.
Dyne Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dyne TherapeuticsInc's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dyne TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Dyne TherapeuticsInc by comparing valuation metrics of similar companies.Dyne TherapeuticsInc is currently under evaluation in market capitalization category among related companies.
Dyne Fundamentals
| Return On Equity | -1.37 | ||||
| Return On Asset | -0.64 | ||||
| Current Valuation | 2.13 B | ||||
| Shares Outstanding | 86.18 M | ||||
| Shares Owned By Insiders | 0.90 % | ||||
| Shares Owned By Institutions | 86.02 % | ||||
| Number Of Shares Shorted | 8.08 M | ||||
| Price To Earning | 35.58 X | ||||
| Price To Book | 24.40 X | ||||
| EBITDA | (239.7 M) | ||||
| Net Income | (235.94 M) | ||||
| Cash And Equivalents | 291.84 M | ||||
| Cash Per Share | 5.64 X | ||||
| Total Debt | 27.41 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 11.63 X | ||||
| Book Value Per Share | 1.49 X | ||||
| Cash Flow From Operations | (188.16 M) | ||||
| Short Ratio | 4.31 X | ||||
| Earnings Per Share | (3.95) X | ||||
| Price To Earnings To Growth | 0.19 X | ||||
| Target Price | 37.75 | ||||
| Number Of Employees | 141 | ||||
| Beta | 0.95 | ||||
| Market Capitalization | 2.23 B | ||||
| Total Asset | 165.08 M | ||||
| Retained Earnings | (632.51 M) | ||||
| Working Capital | 78.28 M | ||||
| Current Asset | 1.93 B | ||||
| Current Liabilities | 809 M | ||||
| Net Asset | 165.08 M |
About Dyne TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dyne TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyne TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyne TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Dyne TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
| 0.71 | ERAS | Erasca Inc Financial Report 20th of May 2024 | PairCorr |
| 0.61 | BMY | Bristol Myers Squibb Financial Report 25th of April 2024 | PairCorr |
Moving against Dyne Stock
| 0.73 | AMGN | Amgen Inc Financial Report 25th of April 2024 | PairCorr |
| 0.71 | BIIB | Biogen Inc Financial Report 23rd of April 2024 | PairCorr |
| 0.64 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dyne TherapeuticsInc Piotroski F Score and Dyne TherapeuticsInc Altman Z Score analysis. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.